Trimethylamine N-oxide and incident atherosclerotic events in high-risk individuals with diabetes: an ACCORD trial post hoc analysis

INTRODUCTION: Type 2 diabetes mellitus (T2D) confers high atherosclerotic cardiovascular disease (ASCVD) risk. The metabolite trimethylamine N-oxide (TMAO) derived via gut flora has been linked to excess ASCVD. RESEARCH DESIGN AND METHODS: We analyzed data, biospecimens, and major adverse cardiovasc...

Descripción completa

Detalles Bibliográficos
Autores principales: Cardona, Andrea, O'Brien, Aaron, Bernier, Matthew C, Somogyi, Arpad, Wysocki, Vicki H, Smart, Suzanne, He, Xin, Ambrosio, Giuseppe, Hsueh, Willa Ann, Raman, Subha V
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2019
Materias:
Cardiovascular and Metabolic Risk
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6861061/
https://www.ncbi.nlm.nih.gov/pubmed/31798892
http://dx.doi.org/10.1136/bmjdrc-2019-000718

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6861061/
https://www.ncbi.nlm.nih.gov/pubmed/31798892
http://dx.doi.org/10.1136/bmjdrc-2019-000718

Ejemplares similares